Curium US
United States Updated 9 July 2026
Curium US is an API manufacturer based in United States. It holds 9 active US drug master files across a filed portfolio of 9 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 18 April 2025 as VAI.
2
registered plants
2 with an FDA FEI number
18
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 18 April 2025 VAI US FDA
- 18 August 2023 VAI US FDA
- 14 June 2019 NAI US FDA
- 13 November 2015 VAI US FDA
- 18 June 2014 NAI US FDA
- 27 March 2013 NAI US FDA
- 6 August 2012 VAI US FDA
- 25 May 2011 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Noblesville, United States | 3011400787 |
| Maryland Heights, United States | 1946929 |
What they file, and where
| Molecule | Regulators | Docs |
| Copper Oxodotreotide Cu-64 | US FDA | 1 |
| Cupric Chloride | US FDA | 1 |
| Gallium Chloride Ga-67 | US FDA | 1 |
| Indium | US FDA | 1 |
| Indium In-111 Chloride | US FDA | 1 |
| Iodide I-123 | US FDA | 1 |
| Leucine | US FDA | 1 |
| Molybdate | US FDA | 1 |
| Pentetic Acid | US FDA | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 18 | 2 |
Comparing suppliers?
Choose your molecules and target markets. Curium US comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 18 April 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates